3.55 -0.10 (-2.76%)
CBLI
Stock Details
Last Trade:3.55 Change:-0.10 (-2.76%) Prev Close:3.65 Open: 3.62 Days Range:3.54 – 3.71 52 Week Range: 1.30 - 6.35 Volume:50300 P/E: N/AEPS:-1.29
View AllRecent Alerts 03/20/10
Recent Alert on 02/26/10 at 12:48pm
Unusual 11 Mid-Day Movers 2/26: RST, CKR, MPET, WAVX, DECK Higher; PMFG, RMTI, CBLI, ORCC Lower
Unusual 11 Mid-Day Movers 2/26: RST, CKR, MPET, WAVX, DECK Higher; PMFG, RMTI, CBLI, ORCC Lower
Rosetta Stone Inc. (NYSE: RST) 26.7% HIGHER; reports Q4 EPS of $0.61, well ahead of the analyst estimate of $0.38. Revenue for the quarter was $78.3 million, which compares to the estimate of $74.31 million. Rosetta Stone sees Q1 EPS of $0.07-$0.09,... Read More
Recent Alert on 02/26/10 at 9:50am
Morning Movers 2/26: CKR, RST, CHCI, HBIO, DECK Higher; RMTI, PMFG, CBLI, DAIO, WTW, ATHN Lower
Morning Movers 2/26: CKR, RST, CHCI, HBIO, DECK Higher; RMTI, PMFG, CBLI, DAIO, WTW, ATHN Lower
Recent Alert on 02/26/10 at 9:29am
Cleveland BioLabs (CBLI) to Raise $5M in Private Placement with Institutional Investors
Cleveland BioLabs (CBLI) to Raise $5M in Private Placement with Institutional Investors
Recent Alert on 02/26/10 at 9:29am
Cleveland BioLabs (CBLI) to Raise $5M in Private Placement with Institutional Investors
Cleveland BioLabs (CBLI) to Raise $5M in Private Placement with Institutional Investors
Recent Alert on 01/28/10 at 9:59am
Cleveland BioLabs (CBLI) Gets Patent for Radiation Protection, Including Protectan CBLB502
Cleveland BioLabs (CBLI) Gets Patent for Radiation Protection, Including Protectan CBLB502
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 09/11/09 at 4:16am
Cleveland BioLabs Sees Promise in Cancer Drug to Negate Chemo Side Effects
Cleveland BioLabs Sees Promise in Cancer Drug to Negate Chemo Side Effects